• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about AstraZeneca PLC

    Recent news which mentions AstraZeneca PLC

    < Previous 1 2 3 4 Next >
    Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
    Tags AstraZeneca PLC Business News Health & Science
    From CNBC.com News
    Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
    Tags Amgen Inc Novo Nordisk A/S Biotech and Pharmaceuticals
    From CNBC.com News
    Friday's big stock stories: What’s likely to move the market in the next trading session
    Tags Warby Parker Inc Mobileye Global Inc Pfizer Inc
    From CNBC.com News
    Cramer's Lighting Round: 'I'm not going to recommend' Altria
    Tags Becton Dickinson and Co Stock markets stocks
    From CNBC.com News
    Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
    Tags Biotech and Pharmaceuticals Health & Science Social issues
    From CNBC.com News
    The 2 things that will drive the stock market after last week's Trump-Fed rally
    Tags IAC Inc Home Improvement Retail ICL Group Ltd
    From CNBC.com News
    Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
    Tags Social issues AstraZeneca PLC Health & Science
    From CNBC.com News
    Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
    Tags Breaking News: Business Health & Science Business News
    From CNBC.com News
    Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
    Tags Advanced Micro Devices Inc Goldman Sachs Group Inc Breaking News: Technology
    From CNBC.com News
    Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
    Tags Eli Lilly and Co Health care industry AstraZeneca PLC
    From CNBC.com News
    AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
    Tags Health care industry Pharmaceuticals Companies
    From CNBC.com News
    AstraZeneca says staff detained in China amid reports of a drug-import investigation
    Tags Business News Biotech and Pharmaceuticals Biotechnology
    From CNBC.com News
    India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
    Tags AstraZeneca PLC Semiconductors International relations
    From CNBC.com News
    India's Modi expected to usher in new era of bilateral agreements in Singapore visit
    Tags Technology Asia Politics Apple Inc
    From CNBC.com News
    Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
    Tags Bristol/Myers Squibb Co Merck & Co Inc Amgen Inc
    From CNBC.com News
    Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
    Tags Health & Science Bristol/Myers Squibb Co Novo Nordisk A/S
    From CNBC.com News
    Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
    Tags Healthy Returns Science AstraZeneca PLC
    From CNBC.com News
    Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
    Tickers CEO
    Tags Investment Strategy Business CEO
    From CNBC.com News
    Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
    Tags Business News U/S/ Markets H/B/ Fuller Company
    From CNBC.com News
    This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
    Tags Investment strategy Biotech and Pharmaceuticals Bristol/Myers Squibb Co
    From CNBC.com News
    AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
    Tags Health World News Europe Markets
    From CNBC.com News
    Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
    Tags Health & Science Business News US: News
    From CNBC.com News
    FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
    Tags Breaking news Business Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
    Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
    From CNBC.com News
    Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
    Tags Health care industry Healthy Returns Health & Science
    From CNBC.com News
    Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
    Tags Johnson & Johnson Health care industry Healthy Returns
    From CNBC.com News
    Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
    Tags Pharmaceuticals Business Health & Science
    From CNBC.com News
    The pet drugs vets are now prescribing look a lot more like human medications
    Tickers CATS DOGS PETS
    Tags Novo Nordisk A/S Pfizer Inc Dogs
    From CNBC.com News
    The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
    Tags Breaking News: Business Goldman Sachs Group Inc Health & Science
    From CNBC.com News
    Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
    Tags Breaking news Weight management Business
    From CNBC.com News
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.